stdClass Object
(
    [blocks_url] => https://learn.docmode.org/api/courses/v2/blocks/?course_id=course-v1%3ARCP%2BRCP006%2B2023_Oct_RCP006
    [effort] => 
    [end] => 2024-11-24T00:00:00Z
    [created] => 2023-10-13T10:05:09.641679Z
    [enrollment_start] => 2023-11-20T00:00:00Z
    [enrollment_end] => 2024-10-24T00:00:00Z
    [id] => course-v1:RCP+RCP006+2023_Oct_RCP006
    [media] => stdClass Object
        (
            [course_image] => stdClass Object
                (
                    [uri] => /asset-v1:RCP+RCP006+2023_Oct_RCP006+type@asset+block@New_Course_card.png
                )

            [course_video] => stdClass Object
                (
                    [uri] => 
                )

            [image] => stdClass Object
                (
                    [raw] => https://learn.docmode.org/asset-v1:RCP+RCP006+2023_Oct_RCP006+type@asset+block@New_Course_card.png
                    [small] => https://learn.docmode.org/asset-v1:RCP+RCP006+2023_Oct_RCP006+type@asset+block@New_Course_card.png
                    [large] => https://learn.docmode.org/asset-v1:RCP+RCP006+2023_Oct_RCP006+type@asset+block@New_Course_card.png
                )

        )

    [name] => Evolving Landscape of Diabetes Management: Balancing Latest and Conventional Approaches for HbA1c Control
    [number] => RCP006
    [org] => RCP
    [short_description] => 
    [start] => 2023-11-24T00:00:00Z
    [start_display] => Nov. 24, 2023
    [start_type] => timestamp
    [pacing] => instructor
    [mobile_available] => 
    [hidden] => 
    [invitation_only] => 
    [payment_url] => https://ecommerce.docmode.org/basket/add/?sku=None
    [course_type] => Course
    [course_price] => 0
    [other_courses] => Array
        (
            [0] => stdClass Object
                (
                    [course_title] => Diabetes and Comorbidity Management
                    [org] => Royal Co..
                    [media] => /asset-v1:RCP+RCP008+2024_Apr_RCP008+type@asset+block@Coursecard-01.png
                    [wp_url] => https://docmode.org/diabetes-and-comorbidity-management
                    [course_type] => Course
                    [start] => Jun 22, 2024 
                )

            [1] => stdClass Object
                (
                    [course_title] => Managing vertigo in routine practice
                    [org] => Royal Co..
                    [media] => /asset-v1:RCP+RCP009+2024_May_RCP009+type@asset+block@Course-card-02.png
                    [wp_url] => https://docmode.org/managing-vertigo-in-routine-practice
                    [course_type] => Course
                    [start] => May 25, 2024 
                )

            [2] => stdClass Object
                (
                    [course_title] => Evolving Landscape of Diabetes Managemen..
                    [org] => Royal Co..
                    [media] => /asset-v1:RCP+RCP006+2023_Oct_RCP006+type@asset+block@New_Course_card.png
                    [wp_url] => https://docmode.org/evolving-landscape-of-diabetes-management-balancing-latest-and-conventional-approaches-for-hba1c-control
                    [course_type] => Course
                    [start] => Nov 24, 2023 
                )

            [3] => stdClass Object
                (
                    [course_title] => Diagnosis, Management, and Evidence-base..
                    [org] => Royal Co..
                    [media] => /asset-v1:RCP+RCP004+2022_Jul_RCP004+type@asset+block@Course_Card.jpg
                    [wp_url] => https://docmode.org/ibs-clinic
                    [course_type] => Lecture
                    [start] => Sep 03, 2022 
                )

            [4] => stdClass Object
                (
                    [course_title] => Specialization on Diabetic Nephropathy
                    [org] => Royal Co..
                    [media] => /asset-v1:RCP+RCP002+2022_May_RCP002+type@asset+block@FACE_RCP_Program_Course_Card-01.jpg
                    [wp_url] => https://docmode.org/specialization-on-diabetic-nephropathy
                    [course_type] => Course
                    [start] => Jul 14, 2022 
                )

            [5] => stdClass Object
                (
                    [course_title] => Advanced Diabetes Management Certification Program
                    [org] => Royal Co..
                    [media] => /asset-v1:RCP+RCP001+2021_Mar_RCP001+type@asset+block@Courses-Card-Alkem.jpg
                    [wp_url] => https://docmode.org/advanced-diabetes-management-certification-program
                    [course_type] => Course
                    [start] => Jul 01, 2021 
                )

        )

    [disclaimer] => Array
        (
        )

    [conversion_rate] => 70
    [course_id] => course-v1:RCP+RCP006+2023_Oct_RCP006
    [overview] =>         
    

        
        





  

            

                
            

          

          

  

  
About This Course

  
Diabetes is a chronic condition characterized by high blood sugar levels, which, if left uncontrolled, can lead to serious health complications. HbA1c is a critical marker that reflects long-term glucose control. Managing HbA1c effectively is crucial in diabetes care, as it reduces the risk of complications.
Balancing the latest innovations, such as advanced medications and technologies, with conventional approaches like lifestyle modifications and established therapies is key. This integrated approach offers patients personalized, comprehensive care, enhancing their ability to maintain optimal HbA1c levels and improve overall well-being while minimizing diabetes-related risks
 
 

  

  

 



    

    
Objectives of the course

    At the completion of this course the participant will be able to:

    
    
     
  • To provide participants with a deep understanding of the evolving landscape of diabetes management, including the conventional approaches as well as the latest advancements.
    • 
     
  • To equip healthcare professionals with the knowledge to effectively control HbA1c levels in diabetic patients, thereby reducing the risk of complications.
    • 
     
  • With examples of real-world case studies and scenarios, attendees will apply their knowledge to practical situations, enhancing their ability to make informed decisions and tailor treatments for improved HbA1c control and patient outcomes.
    • 
     
  • To explore recent updates and recommendations, applying them to practical case studies to enhance their ability to make informed decisions and tailor treatments for improved HbA1c control and patient outcomes.
    • 

    

    

  
  

 

  

    

      
View Syllabus

          
Evolving Landscape of Diabetes Management: Balancing Latest and Conventional Approaches for HbA1c Control
          
By Prof. David Matthews

      

    

  
  



 
 
  
Meet the Instructors

  

    
    

      
Prof. David Matthews

      BM, BCh, MA, DPhil, FRCP, MD (Hon causa)
      
Emeritus Fellow of Harris Manchester College, Oxford
      
 Prof. David Matthews is the recent past President of the European Association for the Study of Diabetes (EASD). He is the Emeritus Founding Chairman of the Oxford Centre for Diabetes, Endocrinology and Metabolism. Emeritus Professor of Diabetic Medicine at the University of Oxford. Past NIHR Senior Investigator and Founding Director of the Oxford Health Alliance. Emeritus Fellow of Harris Manchester College, Oxford. His research interests include personalized medicine, the etiopathology of non-insulin-dependent diabetes, therapeutic agents in type 2 diabetes, mathematical modelling of insulin resistance, homeostatic model assessment of beta-cell function and insulin resistance (HOMA and iHOMA), the incretin axis and glucagon-like peptide-1, pulsatile insulin secretion, and the global obesity epidemic. Dr. David Matthews was on the steering committee of the UKPDS. He gave the Banting Memorial Lecture at Diabetes UK (‘Type 2 diabetes: the Black Death of the 21st century’), lectures widely on therapeutics, personalised medicine, and mathematical modelling. He chaired the EASD/ADA group that produced the international guidelines on the treatment of type 2 diabetes – both in 2012 and in 2015. He is co-chair of the CANVAS and CANVAS-R phase III studies investigating cardiovascular outcomes with canagliflozin. He is co-chair of the VERIFY trial which examined the use of vildagliptin early in T2DM to avoid primary therapeutic failure. He has authored more than 320 academic peer-reviewed publications.


 

    

  

 





  




  

  
Course FAQs
  
    
    

      
      

        
        
        
        

          

            Consulting and general physicians.
          

        

      

      
      
      

        
        
        
        

          

            The course is organized into 1 module. Registration for the course is always open and participants may
            begin the course at any time.
          

        

      

      
      
      

        
        
        
        

          

            Course is Free.
          

        

      

      
      
      

        
        
        
        

          

            As soon as you enroll in a course, Once the course begings, you will have access to all videos, tests, and assignments (if applicable). 
          

        

      

      
      
      

        
        
        
        

          

            Yes, some background knowledge pertaining the subject will be necessary.
          

        

      


      
      
      

        
        
        
        

          

            Yes. Experience in this field in necessary.  
          

        

      

    

  











)


About This Course

Diabetes is a chronic condition characterized by high blood sugar levels, which, if left uncontrolled, can lead to serious health complications. HbA1c is a critical marker that reflects long-term glucose control. Managing HbA1c effectively is crucial in diabetes care, as it reduces the risk of complications.
Balancing the latest innovations, such as advanced medications and technologies, with conventional approaches like lifestyle modifications and established therapies is key. This integrated approach offers patients personalized, comprehensive care, enhancing their ability to maintain optimal HbA1c levels and improve overall well-being while minimizing diabetes-related risks


Objectives of the course

At the completion of this course the participant will be able to:
  • To provide participants with a deep understanding of the evolving landscape of diabetes management, including the conventional approaches as well as the latest advancements.
  • To equip healthcare professionals with the knowledge to effectively control HbA1c levels in diabetic patients, thereby reducing the risk of complications.
  • With examples of real-world case studies and scenarios, attendees will apply their knowledge to practical situations, enhancing their ability to make informed decisions and tailor treatments for improved HbA1c control and patient outcomes.
  • To explore recent updates and recommendations, applying them to practical case studies to enhance their ability to make informed decisions and tailor treatments for improved HbA1c control and patient outcomes.

View Syllabus

Evolving Landscape of Diabetes Management: Balancing Latest and Conventional Approaches for HbA1c Control
By Prof. David Matthews


Meet the Instructors

Prof. David Matthews

BM, BCh, MA, DPhil, FRCP, MD (Hon causa)
Emeritus Fellow of Harris Manchester College, Oxford

Prof. David Matthews is the recent past President of the European Association for the Study of Diabetes (EASD). He is the Emeritus Founding Chairman of the Oxford Centre for Diabetes, Endocrinology and Metabolism. Emeritus Professor of Diabetic Medicine at the University of Oxford. Past NIHR Senior Investigator and Founding Director of the Oxford Health Alliance. Emeritus Fellow of Harris Manchester College, Oxford. His research interests include personalized medicine, the etiopathology of non-insulin-dependent diabetes, therapeutic agents in type 2 diabetes, mathematical modelling of insulin resistance, homeostatic model assessment of beta-cell function and insulin resistance (HOMA and iHOMA), the incretin axis and glucagon-like peptide-1, pulsatile insulin secretion, and the global obesity epidemic. Dr. David Matthews was on the steering committee of the UKPDS. He gave the Banting Memorial Lecture at Diabetes UK (‘Type 2 diabetes: the Black Death of the 21st century’), lectures widely on therapeutics, personalised medicine, and mathematical modelling. He chaired the EASD/ADA group that produced the international guidelines on the treatment of type 2 diabetes – both in 2012 and in 2015. He is co-chair of the CANVAS and CANVAS-R phase III studies investigating cardiovascular outcomes with canagliflozin. He is co-chair of the VERIFY trial which examined the use of vildagliptin early in T2DM to avoid primary therapeutic failure. He has authored more than 320 academic peer-reviewed publications.



Course FAQs

Consulting and general physicians.
The course is organized into 1 module. Registration for the course is always open and participants may begin the course at any time.
Course is Free.
As soon as you enroll in a course, Once the course begings, you will have access to all videos, tests, and assignments (if applicable).
Yes, some background knowledge pertaining the subject will be necessary.
Yes. Experience in this field in necessary.